ADERIS PHARMACEUTICALS Trademark

Trademark Overview

On Monday, August 20, 2001, a trademark application was filed for ADERIS PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the ADERIS PHARMACEUTICALS trademark a serial number of 76976684. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 30, 2011. This trademark is owned by Discovery Therapeutics, Inc.. The ADERIS PHARMACEUTICALS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Product research and development services, namely, development, production, commercialization, design, and research of cardiovascular and renal therapeutics for others
aderis pharmaceuticals

General Information

Serial Number76976684
Word MarkADERIS PHARMACEUTICALS
Filing DateMonday, August 20, 2001
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 30, 2011
Registration Number2955474
Registration DateTuesday, May 24, 2005
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 17, 2002

Trademark Statements

Disclaimer with Predetermined Text"PHARMACEUTICALS"
Goods and ServicesProduct research and development services, namely, development, production, commercialization, design, and research of cardiovascular and renal therapeutics for others

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 30, 2011
Primary Code042
First Use Anywhere DateMonday, December 31, 2001
First Use In Commerce DateMonday, December 31, 2001

Trademark Owner History

Party NameADERIS PHARMACEUTICALS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressHOPKINTON, MA 01748
Party NameADERIS PHARMACEUTICALS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHOPKINTON, MA 01748
Party NameADERIS PHARMACEUTICALS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressHOPKINTON, MA 01748
Party NameDiscovery Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHopkinton, MA 01748

Trademark Events

Event DateEvent Description
Friday, December 30, 2011CANCELLED SEC. 8 (6-YR)
Tuesday, May 24, 2005REGISTERED-PRINCIPAL REGISTER
Wednesday, March 23, 2005LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, March 23, 2005ASSIGNED TO LIE
Monday, March 14, 2005ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sunday, March 13, 2005PREVIOUS ALLOWANCE COUNT WITHDRAWN
Sunday, March 13, 2005ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, January 5, 2005AMENDMENT FROM APPLICANT ENTERED
Thursday, December 23, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 5, 2005ASSIGNED TO LIE
Thursday, December 23, 2004TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 28, 2004NON-FINAL ACTION MAILED
Thursday, June 3, 2004PAPER RECEIVED
Monday, April 26, 2004ASSIGNED TO EXAMINER
Thursday, April 22, 2004STATEMENT OF USE PROCESSING COMPLETE
Friday, April 9, 2004USE AMENDMENT FILED
Thursday, April 22, 2004DIVISIONAL PROCESSING COMPLETE
Friday, April 9, 2004DIVISIONAL REQUEST RECEIVED
Friday, April 9, 2004PAPER RECEIVED
Friday, March 26, 2004EXTENSION 2 GRANTED
Thursday, March 11, 2004EXTENSION 2 FILED
Thursday, March 11, 2004TEAS EXTENSION RECEIVED
Thursday, September 11, 2003EXTENSION 1 GRANTED
Thursday, August 21, 2003EXTENSION 1 FILED
Thursday, August 21, 2003PAPER RECEIVED
Tuesday, March 11, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 17, 2002PUBLISHED FOR OPPOSITION
Wednesday, November 27, 2002NOTICE OF PUBLICATION
Saturday, October 19, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 18, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 5, 2002FINAL REFUSAL MAILED
Wednesday, June 5, 2002ASSIGNED TO EXAMINER
Thursday, April 11, 2002PAPER RECEIVED
Wednesday, January 30, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 2, 2001NON-FINAL ACTION MAILED
Saturday, September 29, 2001ASSIGNED TO EXAMINER

Related Keywords

pharmaceuticals aderis development research cardiovascular renal others design therapeutics production services namely